Sun Hak Lee

Title: Innovations by Sun Hak Lee in Cancer Diagnosis and Treatment

Introduction

Sun Hak Lee is an accomplished inventor based in Pohang-si, South Korea. He has made significant contributions to the field of medical diagnostics and treatment, particularly in cancer research. With a total of two patents to his name, Lee's work focuses on innovative methods that utilize nucleolin-specific aptamers.

Latest Patents

Lee's latest patents include a method of diagnosing cancer using a nucleolin-specific aptamer. This patent details improved G-rich oligonucleotide (GRO) aptamers that are specific to nucleolin, along with a method for preparing these aptamers. The patent also outlines the use of these aptamers for diagnosing and/or treating nucleolin-associated diseases. Another notable patent by Lee is a method of treating hyperproliferation of cells using a nucleolin-specific aptamer. Similar to his previous work, this patent describes improved GRO aptamers specific to nucleolin and their application in diagnosing and treating related diseases.

Career Highlights

Sun Hak Lee is affiliated with the Postech Academy-Industry Foundation, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on cancer treatment and diagnostics.

Collaborations

Lee collaborates with notable colleagues, including Jung Hwan Lee and Soon Hag Kim, who contribute to his research endeavors.

Conclusion

Sun Hak Lee's innovative work in the field of cancer diagnosis and treatment showcases the potential of nucleolin-specific aptamers. His contributions are paving the way for advancements in medical science and improving patient outcomes.